Compare Eli Lilly And Co (LLY) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs 22nd Century Group Inc — how do they compare? Eli Lilly And Co trades at $1,174.1 (market cap $1.02T), while 22nd Century Group Inc trades at $4.25 (market cap $1.49M). The key difference: Eli Lilly And Co is far larger — about 684563.8× 22nd Century Group Inc's market cap, and Eli Lilly And Co pays a 0.6% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| LLY | XXII | |
|---|---|---|
Market Cap | $1.02T | $1.49M |
Sector | Health | Technology |
52-Week High | $1.24K | $1.07K |
52-Week Low | $625.65 | $3.90 |
Enterprise Value | $1.06T | -$6.74M |
Dividend Yield | 0.6% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
